Overview


According to FutureWise analysis the market for Alopecia Treatment is expected to grow at a CAGR of 7.30% during the forecast period of 2023-2031.

Alopecia treatment encompasses a range of approaches aimed at managing and addressing hair loss caused by alopecia, a condition characterized by the sudden loss of hair in round or oval patches on the scalp or other parts of the body. The goal of treatment is to promote hair regrowth, slow down further hair loss, and mitigate the emotional impact of hair loss on individuals. When it comes to treating alopecia, the decision on what method to use will be based on a few factors. These include the type and severity of the alopecia, any underlying causes, and the personal preferences of the individual.

There are various treatments available for Alopecia. Applying medicines such as topical corticosteroids and minoxidil (Rogaine) on the scalp can help in hair growth, decrease inflammation, and slow down hair loss. Injectable corticosteroids are another option, where corticosteroid solutions are injected into the affected areas to suppress inflammation and promote regrowth. In more severe cases, systemic immunotherapy may be prescribed, involving the use of immune-modulating medications like corticosteroids or immune-suppressing drugs. Surgical procedures like hair transplantation can be considered for individuals with advanced or permanent hair loss, while non-medical approaches like wigs, hairpieces, and camouflage techniques provide cosmetic solutions to conceal hair loss.

FutureWise Market Research has published a report that provides an insightful analysis of alopecia treatment market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. By the end of the forecast period FutureWise research analysts projects that alopecia treatment market will experience a significant growth.

According to the analysis done, this report will help understand the information referring to the total valuation held by this industry. Additionally, this report will help in understanding the growth opportunities held by various segments of this market, further assist in making better strategic and expansion decisions by key stakeholders of an organization.

  • Johnson and Johnson, Inc.
  • Merck & Co., Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Dr. Reddy’s Laboratories Ltd.
  • Cipla Ltd
  • Cellmid Ltd
  • The Himalaya Drug Company
  • Taisho Pharmaceutical Holdings Co., Ltd
  • Shiseido Co., Ltd
  • Zhangguang 101 Science and Technology Co., Ltd
  • Vitabiotics
  • Sun Pharma
  • Alpecin
  • Kirkland Signature
  • Phyto Ales Group
  • Lifes2good

(Note: The list of the major players will be updated with the latest market scenario and trends)

Recent developments by key players in the Alopecia Treatment Market:

  • In August 2021, Pfizer has reported encouraging results from its Phase 2b/3 ALLEGRO trial of ritlecitinib, an oral medication designed to treat alopecia areata. After six months of treatment, the drug has successfully achieved the primary efficacy endpoint of reducing scalp hair loss.

Hair loss and baldness are widespread and concerning problems that affect millions of individuals worldwide. Both men and women of all ages can suffer from hair loss due to various underlying causes such as genetic predisposition or hormonal imbalances. Although hair loss is not a life-threatening condition, it can impact an individual's physical appearance and self-esteem, leading to social anxiety and depression in severe cases. Therefore, finding effective alopecia treatment options is crucial. Fortunately, there are now various innovative therapies and products available, including topical creams, oral medications, hair transplants, and scalp micropigmentation, that can help stimulate hair growth and restore a full head of hair. However, stakeholders must carefully consider market dynamics influenced by factors such as healthcare expenditure, regulatory environment, and reimbursement policies to ensure the best possible outcomes for all parties involved. In addition to medical treatments, individuals can also make various lifestyle changes to promote healthy hair growth and prevent further hair loss by maintaining a balanced diet rich in nutrients, reducing stress levels, avoiding harsh chemicals and heat styling tools, and staying hydrated. To maintain the health and beauty of your hair, it's crucial to adopt a thorough hair care regimen that considers all the essential aspects. 

By Alopecia Type

  • Alopecia Areata
  • Alopecia Totalis
  • Alopecia Universalis

By Treatment Type

  • Topical Drugs
    • Creams
    • Oils
    • Gels
    • Shampoo
    • Lotions
    • Foams
  • Oral Drugs
  • Injectable Drugs
    • Platelet-rich Plasma
    • Injections
    • Injectable Fillers
  • Hair Transplant Services
  • Low-level Laser Therapy

By End-User

  • Hospitals
  • Dermatologic and Trichology Clinics
  • Home Care Settings
  • Aesthetic Clinics

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. The Alopecia Treatment (Hair Loss) market in North America is recognized as a significant player in the global market. This can be attributed to the region's advanced healthcare infrastructure, high disposable income, and access to innovative therapeutic options. Alopecia areata is a widespread form of hair loss that medical professionals acknowledge as the second most common after androgenetic alopecia. This condition affects a significant number of individuals, with stats from the United States National Library of Medicine indicating that around 1 in every 500 to 1,000 people are affected. It occurs equally in both men and women and affects people of all ethnic backgrounds. Hair loss is a significant factor in driving the North American market due to its high prevalence and treatment rates.

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Alopecia Treatment Market By Alopecia Type, By Treatment Type, By End-user and By Region.
  • To cater comprehensive insights on factors such as drivers, restraints, trends, opportunity, and additionally segmental and regional factors impacting market growth.
  • To evaluate current market trends and forecast micro-markets and the overall market projections which are represented in the format of data-sets and ppt.
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa. 
  • To provide information on competitors which includes landscape mapping, technological advancements, R&D spending, news concerning strategic alliances, and new product launches

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Alopecia Treatment Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Alopecia Treatment Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Alopecia Treatment Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Alopecia Treatment Market, By Alopecia Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Alopecia Areata
        2. Alopecia Totalis
        3. Alopecia Universalis

  • 8.   Alopecia Treatment Market, By Treatment Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Topical Drugs
         1.1. Creams
         1.2. Oils
         1.3. Gels
         1.4. Shampoo
         1.5. Lotions
         1.6. Foams
        2. Oral Drugs
        3. Injectable Drugs
         3.1. Platelet-rich Plasma
         3.2. Injections
         3.3. Injectable Fillers
        4. Hair Transplant Services
        5. Low-level Laser Therapy

  • 9.   Alopecia Treatment Market, By End-User Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Hospitals
        2. Dermatologic and Trichology Clinics
        3. Home Care Settings
        4. Aesthetic Clinics

  • 10.   North America Alopecia Treatment Market Analysis 2023-2031 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country,2023-2031
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 11.   Latin America Alopecia Treatment Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 12.   Europe Alopecia Treatment Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 13.   Asia Pacific Alopecia Treatment Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 14.   Middle East and Africa Alopecia Treatment Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 15.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 16.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •         1. Johnson and Johnson, Inc.
                 1.1. Company Overview
         1.2. Alopecia Type Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Merck & Co., Inc.
         2.1. Company Overview
         2.2. Alopecia Type Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Teva Pharmaceutical Industries Ltd.
         3.1. Company Overview
         3.2. Alopecia Type Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Dr. Reddy’s Laboratories Ltd..
         4.1. Company Overview
         4.2. Alopecia Type Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Cipla Ltd.
         5.1. Company Overview
         5.2. Alopecia Type Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Cellmid Ltd.
         6.1. Company Overview
         6.2. Alopecia Type Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. The Himalaya Drug Company
         7.1. Company Overview
         7.2. Alopecia Type Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Taisho Pharmaceutical Holdings Co., Ltd
         8.1. Company Overview
         8.2. Alopecia Type Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Shiseido Co., Ltd.
         9.1. Company Overview
         9.2. Alopecia Type Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Zhangguang 101 Science and Technology Co., Ltd.
         10.1. Company Overview
         10.2. Alopecia Type Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11. Vitabiotics
         11.1. Company Overview
         11.2. Alopecia Type Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview
        12. Sun Pharma
         12.1. Company Overview
         12.2. Alopecia Type Portfolio
         12.3. SWOT Analysis
         12.4. Financial Overview
         12.5. Strategic Overview
        13. Alpecin
         13.1. Company Overview
         13.2. Alopecia Type Portfolio
         13.3. SWOT Analysis
         13.4. Financial Overview
         13.5. Strategic Overview
        14. Kirkland Signature
         14.1. Company Overview
         14.2. Alopecia Type Portfolio
         14.3. SWOT Analysis
         14.4. Financial Overview
         14.5. Strategic Overview
        15. Phyto Ales Group
         15.1. Company Overview
         15.2. Alopecia Type Portfolio
         15.3. SWOT Analysis
         15.4. Financial Overview
         15.5. Strategic Overview
        16. Lifes2good
         16.1. Company Overview
         16.2. Alopecia Type Portfolio
         16.3. SWOT Analysis
         16.4. Financial Overview
         16.5. Strategic Overview

  • 17.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the regulations initiated by healthcare administrations
        5. The overall economic slowdown of the developing and developed nations
  • 18.   FutureWise SME Key Takeaway Points for Client

Related Market

Alopecia Drugs Market

Read More

Alopecia Market

Read More

Alopecia Areata Market

Read More
Partner

Our Clients